Etanercept for Wegener's Granulomatosis

NCT00005007 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

181

Enrollment

NIH

Sponsor class

Conditions

Wegener's Granulomatosis

Interventions

DRUG: Etanercept

Sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborators

[object Object]